A novel plasma proteinase potentiates α2-antiplasmin inhibition of fibrin digestion

Blood

Volumn 103, Issue 10, 2004, Pages 3783-3788

  Lee, Kyung N ^a,b   Jackson, Kenneth W ^a   Christiansen, Victoria J ^a   Chung, Keun H ^a   McKee, Patrick A ^a,b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b BSEB 306   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTIPLASMIN CLEAVING ENZYME; ASPARAGINE; BLOOD CLOTTING FACTOR 13; FIBRIN; METHIONINE; PLASMIN; PROLINE; PROTEINASE; SERINE PROTEINASE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; ATHEROGENESIS; BLOOD CLOT LYSIS; BLOOD CLOTTING; DRUG TARGETING; ENZYME MECHANISM; ENZYME PURIFICATION; ENZYME STRUCTURE; ENZYME SUBSTRATE; FIBRINOLYSIS; FIBROBLAST; HUMAN; INFLAMMATION; PLASMA; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DEGRADATION; THROMBOSIS;

EID: 2342447229     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-12-4240     Document Type: Article

References (31)

1. Mullertz S, Clemmensen I. The primary inhibitor of plasmin in human plasma. Biochem J. 1976; 159:545-563.
2. Collen D. The plasminogen (fibrinolytic) system. Thromb Haemost. 1999;82:259-270.
3. 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. J Clin Invest. 1980;65:290-297.
4. 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis. J Clin Invest. 1982;69: 538-542.
5. 2-antiplasmins: fibrinolysis enhancement by reactive site mutant. Blood. 1999;94:164-171.
6. 2-plasmin inhibitor deficiencies. Br J Haematol. 2001;114:4-10.
7. 2-plasmin inhibitor from human plasma and culture media of Hep G2 cells. Biochem Biophys Res Commun. 1994;200:417-422.
8. 2-plasmin inhibitor in human plasma. Biochem J. 1993;291:623-625.
9. Sumi Y, Ichikawa Y, Nakamura Y, Miura O, Aoki N. Expression and characterization of pro α2-plasmin inhibitor. J Biochem. 1989;108:703-707.
10. 2-antiplasmin. Biochem J. 1980;191:229-232.
11. Tam JP. Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proc Natl Acad Sci U S A. 1988;85:5409-5413.
12. Folk JE, Chung SI. Transglutaminases. Method Enzymol. 1985;113:359-375.
13. 2-antiplasmins to fibrin by activated factor XIII and by a tissue transglutaminase. J Biol Chem. 2000;275:37382-37389.
14. Beebe D, Aronson D. An automated fibrinolytic assay performed in microtiter plates. Thromb Res. 1987;47:123-128.
15. Jones A, Meunler A. A precise and rapid microtitra plate clot lysis assay: methodology, kinetic modeling and measurement of catalytic constants for plasminogen activation during fibrinolysis. Thromb Haemost. 1990;64:455-463.
16. 2-antiplasmin on urokinase-induced fibrinolysis. Thromb Haemost. 1998;80:637-644.
17. 2-antiplasmin and of mutants obtained by site-directed mutagenesis of the reactive site. Biochemistry. 1987;26:5133-5136.
18. 2-antiplasmin with affinity for plasminogen is selectively bound to fibrin by factor XIII. Thromb Res. 1984;33:419-425.
19. Sugiyama N, Sasaki T, Iwamoto M, Abiko Y. Binding site of α2-plasmin inhibitor to plasminogen. Blochim Biophys Acta. 1988;952:1-7.
20. Cunningham DF, O'Connor B. Proline specific peptidases. Biochim Biophys Acta 1997;1343: 160-186.
21. Bimey YA, O'Connor BF. Purification and characterization of a Z-pro-prolinal-insensitive Z-Gly-Pro-7-amino-4-methyl coumarin-hydrolyzing peptidase from bovine serum: a new prollne-specific peptidase. Protein Expr Purif. 2001;22:286-298.
22. Scanlan MJ, Raj BK, Calvo B, et al. Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc Natl Acad Sci U S A. 1994;91:5657-5681.
23. Goldstein LA, Ghersi G, Pineiro-Sanchez ML, et al. Molecular cloning of seprase: a serine integral membrane protease from human malanoma. Biochim Biophys Acta. 1997;1361:11-19.
24. Jeno P, Mini T, Moes S, Hintermann E, Horst M. Internal sequences from proteins digested in polyacrylamide gels. Anal Biochem. 1995;224:75-82.
25. Garin-Chesa P, Old LJ, Rettig WJ. Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc Natl Acad Sci U S A. 1990;87:7235-7239.
26. Ghersi G, Dong H, Goldstein LA, et al. Regulation of fibroblast migration on collagenous matrix by a cell surface peptidase complex. J Biol Chem. 2002;277:29231-29241.
27. Park JE, Lenter MC, Zimmermann RN, Garin-Chesa P, Old LJ, Rettig WJ. Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J Biol Chem. 1999;274:36505-36512.
28. Schmidt A, Muller D, Mersmann M, et al. Generation of human high-affinity antibodies specific for the fibroblast activation protein by guided selection. Eur J Biochem. 2001;268:1730-1738.
29. Iwaki-Egawa S, Watanabe Y, Kikuya Y, Fujimoto Y. Dipeptidyl peptidase IV from human serum: purification, characterization, and N-terminal amino acid sequence. J Biochem. 1998;124:428-433.
30. Netzel-Arnett S, Sang QX, Moore WG, et al. Comparative sequence specificities of human 72- and 92-kDa gelatinases (type IV collagenases) and PUMP (matrilysin). Biochemistry. 1993;32: 6427-6432.
31. 2-antiplasmin into fibrin. Thromb Haemost. 2003;1:OC334.